Results 31 to 40 of about 2,720 (214)
Plastic and Reconstructive Surgery, Global Open, 2023 Background:. Dupuytren disease is associated with inflammation and myofibroblast overgrowth, as is stenosing tenosynovitis (trigger finger). Both are linked with fibroblast proliferation, but a potential associative link between the diseases is unknown ...
Michael B. Gehring, MD +5 more
doaj +1 more source
Collagenase Dupuytren Contracture: Achieving Single Treatment Success with a Hand Therapist-Based Protocol. [PDF]
Plast Reconstr Surg Glob Open, 2016 Malafa MM +3 more
europepmc +2 more sources
Surgical treatment results for dupuytren's disease [PDF]
Acta Ortopédica Brasileira, 2017 OBJECTIVE: To present the results of our cases of Dupuytren's disease treated with regional selective fasciectomy in light of the literature. METHODS: Patients diagnosed with Dupuytren's contracture and surgically treated with regional selective ...
Serkan Aykut +5 more
doaj +1 more source
Plastic and Reconstructive Surgery, Global Open, 2023 Summary:. Collagenase Clostridium histolyticum is a popular treatment in Dupuytren contracture. Current guidelines are for manipulation 24 hours to 7 days after injection. We present a case of successful manipulation 28 days after injection.
Lacey R. Pflibsen, MD +2 more
doaj +1 more source
Plantar fibromatosis and Dupuytren’s contracture in an adolescent [PDF]
Vojnosanitetski Pregled, 2011 Background. Fibromatosis represents a wide group of benign, locally proliferative disorders of fibroblasts. Dupuytren` s disease is a benign proliferative disease of palmar aponeurosis which usually affects adults between 40 and 60 years of age ...
Nikolić Jelena +4 more
doaj +1 more source
Palmar and plantar fibromatosis: a review [PDF]
Journal of Pathology and Translational Medicine, 2021 Palmar fibromatosis (Dupuytren disease/contracture) is the most common type of fibromatosis, defined as a benign proliferation of fibroblasts and myofibroblasts.
Brian D. Stewart +1 more
doaj +1 more source
Biomedicines, 2023 In Dupuytren disease, little is known about the long-term outcomes of collagenase injection or risk factors for contracture recurrence. In this prospective study, 159 patients (242 fingers) with Dupuytren disease and active extension deficit (AED) ≥20 ...
David Eckerdal +3 more
doaj +1 more source
Systematic review of non-surgical treatments for early Dupuytren’s disease [PDF]
, 2015 Introduction There is no approved treatment for early Dupuytren’s disease (DD) to prevent progression of flexion deformities requiring subsequent treatment with invasive procedures.
Catherine Ball +4 more
core +4 more sources
Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy? [PDF]
, 2015 Dupuytren's contracture (DC) is a benign fibro-proliferative disease of the hand causing fibrotic nodules and fascial cords which determine debilitating contracture and deformities of fingers and hands.
Alberto Signore +11 more
core +1 more source
Current Orthopaedics, 1986 Abstract The subject of Dupuytren's contraction of the fingers is one that has interested me for many years, and occasionally at long intervals it may be useful to review one's own personal experience, and explain any change in opinion or treatment that I may have adopted; also to notice any theories of causation suggested, and additions to the ...
+6 more sources